Treatment for liver metastases from breast cancer: Results and prognostic factors

Table 1 Basic clinical data between the two groups.

Factors	A group	B group	P
Age (yr)	53.13±9.23	55.65±12.32	0.412
The type of primary breast cancer infiltrating ductal carcinoma/simple carcinoma/adenocarcinoma	26/0/2	18/2/0	0.12
Method of treatment for primary tumor surgery/postoperative radiotherapy/postoperative chemotherapy	28/10/27	20/9/20	0.911
Interval time between the primary tumor and metastasis (mo)	31.21±24.56	27.23±22.97	0.11
Number of liver metastasis single/multi	9/19	5/15	0.591
Stage of liver metastasis
I/II/III/IV	10/10/6/2	10/6/3/1	0.794

Criteria of liver metastasis staging see Gennari’s staging system[15]. A group: TACE group; B group: systemic chemotherapy group.